Jorge Armando Quiroz
CIK 1727401 · View on SEC EDGAR ↗
First SEC filing: Jan. 25, 2018 · Latest: Jan. 25, 2018
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 3, 2018 | SLDB | S 10b5-1 | 1,370 | $32.24 | $44,169 | 228,092 Direct | -0.60% | Disposed | -98.1% (price as of 2026-08-21) |
| Dec. 3, 2018 | SLDB | S 10b5-1 | 31,426 | $31.41 | $987,091 | 229,462 Direct | -12.05% | Disposed | -98.0% (price as of 2026-08-21) |
| Dec. 3, 2018 | SLDB | S 10b5-1 | 6,154 | $30.21 | $185,912 | 260,888 Direct | -2.30% | Disposed | -97.9% (price as of 2026-08-21) |
| Dec. 3, 2018 | SLDB | S 10b5-1 | 1,200 | $29.94 | $35,928 | 267,042 Direct | -0.45% | Disposed | -97.9% (price as of 2026-08-21) |
| Nov. 16, 2018 | SLDB | S 10b5-1 | 100 | $34.90 | $3,490 | 268,242 Direct | -0.04% | Disposed | -98.2% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 23, 2019 | SLDB | Employee Stock Option (Right to Buy) | Common Stock (60,000) | $22.93 | Jan. 23, 2029 | 60,000 | Acquired |
| Feb. 14, 2018 | SLDB | Employee Stock Option (Right to Buy) | Common Stock (47,061) | $26.23 | Feb. 14, 2028 | 47,061 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 25, 2018 | SLDB | Common Stock | 268,342 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
SLDB
M.D., Former Chief Medical Officer(3)| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2019 | $412,500 | $113,400 | — | $1,015,308 | — | — | — | $1,541,208 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.